mbt-boots.com

Monday, February 16, 2009

In the 1970s, she was one of the most popular female vocalists in France, and became well-known internationally. Anne Marie David, from Arles in the south of France, parlayed her initial success from playing Mary Magdalene in the French production of Jesus Christ Superstar into taking home the “grand prix” at the Eurovision Song Contest in 1973. Her winning song, “Tu te reconnaîtras” (You will recognize yourself), became a Europe-wide hit that spring.

At the height of her popularity, David perfomed world tours, and even lived abroad in Turkey for a time. In 1979, she tried once again to win the Eurovision, and placed a respectable third. Her song “Je suis l’enfant soleil” (I’m a child of the sun) became similarly popular across France and in the Francophone nations.

As time went on, however, her place in the French music scene became less certain. Touring the world had taken a personal toll, and David decided to retire from music completely in 1987. However, with the help of her fan base, she was coaxed out of retirement in 2003 and is returning to a part of her life that she tried to leave, but never left her. Celebrating four decades in the music scene, David is looking forward to adventurous new projects and a newfound zest for life.

Anne Marie David corresponded with Wikinews’ Mike Halterman about her eventful career, her personal anecdotes regarding living abroad, her successes in past Eurovision contests and her grievances with the way the show is produced today. This is the second in a series of interviews with past Eurovision contestants, which will be published sporadically in the lead-up to mid-May’s next contest in Moscow.

Sunday, July 24, 2005

The World Health Organization’s Beijing spokesman has said that the People’s Republic of China has withheld vital information regarding H5N1 outbreaks, a type of bird flu that is infecting animals throughout Asia. The animals most affected by the disease are those among waterfowl and poultry, however in recents months it has infected humans and has also been discovered in tigers as well as swine. The Nation magazine quotes WHO officials as saying that the strain has the potential of causing a human pandemic (global epidemic) resulting in tens of millions of deaths.

The first appearance of this type of flu was in Hong Kong during 1997. As of July 21, 2005, one hundred and nine cases of human infection have been confirmed resulting in fifty five deaths outside of China reports the Centers for Disease Control. China has reported no deaths in the recent outbreaks, leading to speculation of a cover up. The Economist says eleven countries across Asia have been affected, and more than one hundred and twenty million birds have died from infection or been culled. Although this week a case was found in Russia making it the first European country with an infection and twelfth in the world.

Usually these flu viruses are carried worldwide by wild bird populations in their intestines and are non-lethal. However this variant has mutated into the most lethal strain of influenza ever recorded says Mike Davis, author of The Monster at Our Door: The Global Threat of Avian Flu. Such occurrences are natural and have happened in the past as in the 1918 Spanish influenza pandemic.

The current virus is morphing into a type that is spread among humans with the first human-to-human cases found in Vietnam during 2005. When avian influenza subtypes adapt for this mode of transmission the effect is deadly for humans as the immune system has no natural immunities for it and the production of appropriate antibodies to fight the infection takes some time.

Further complicating the effort to combat H5N1, it was reported in the Washington Post that the People’s Republic of China has been administering the medication Amantadine to poultry in violation of international livestock regulations that state it is for human use only since the late-1990s (all the time officially denying any cases of bird flu among its poultry); the result has been that the virus is now largely immune to the medication and is significantly deadlier. World Health Organization officials had been preparing to use the drug to fight a future pandemic and now it has been rendered useless.

Chinese government officials have said more than 1,000 migratory birds have been found dead during 2005 and there have been unofficial Internet reports of one hundred and twenty related human fatalities that are strongly denied by Beijing.

China has previously irked international agencies for its handling of public and agricultural health crises, notably the SARS epidemic that began in 2002. China’s health minister was fired after the government acknowledged it had covered up the extent of the SARS outbreak by preventing reports about the illness for months and by minimizing its seriousness says the Washgington Post.

Margaret Chan, WHO director of pandemic influenza preparedness is pressing China to allow laboratories to examine specimens from birds in Qinghai, where the H5N1 virus has killed more than 5,000 birds from five species. Recombinomics has found Chinese message boards indicating part of Qinghai province may be under martial law and quarantine.

Three outbreaks of H5N1 have affected China in recent months but the World Health Organization has not received the information or the virus samples from infected birds that they requested. “It is a matter of urgency,” said Roy Wadia, the WHO’s speaker in China. “We stress that this virus is highly unpredictable and versatile and can change any time. It is highly dangerous.”

Monday, February 17, 2014

On Friday afternoon, amateur shooters were briefed about a three-year-long trial of hunting in national parks of New South Wales, Australia. The meeting was held in Griffith near Cocopara Nature Reserve, where the first shooting operation of the trial was to occur on Saturday, targeting the feral goats.

The National Parks Wildlife Service (NPWS) has used aerial culls and baiting to reduce Cocoparra’s goat population, but there are said to be thousands of goats at the reserve. The feral animals to be hunted in other reserves may include cats, deer, dogs, and pigs, beside goats — depending on the reserve.

Shooters in the supplementary pest control trial were to be closely supervised by rangers, as the trial was monitored and its effectiveness evaluated. In a partnership of NPWS and the Sporting Shooters Association of Australia (NSW) Inc, qualified volunteers were recruited, under the Sporting Shooters Association’s hunting program. According to Mick O’Flynn, the Acting Director Park Conservation and Heritage with the NPWS, the four shooters selected for the first shooting operation received comprehensive safety and training instruction.

Following announcement of the close partnership of shooters with NWPS staff, the Greens cancelled planned picketing of the first shooting operation. However, State Greens MP (Member of Parliament) David Shoebridge warned, “This needs to be a government-run program, not run by the biggest gun lobby group in Australia”. He called limiting the meeting to members of the Sporting Shooters Association “outrageous”. Another concern raised by the Greens was the danger of armed people, not only to animals, but also to people visiting the national parks, should the shooters be unsupervised after the trial.

The trial was announced in the second half of 2013, though the plan has been significantly modified over time and has come to be regulated under the National Parks and Wildlife Act, in contrast with the original proposal of recreational hunting in national parks, as it was announced in May 2012 by New South Wales Premier Barry O’Farrell. This amendment of the Game and Feral Animal Control Act was part of a deal with the Shooters and Fishers Party. The government needed at least one vote from a Shooters and Fishers Party MP to pass electricity privatisation legislation, as both Labor and Greens opposed it. O’Farrell’s plans to allow pest control by licensed individuals called for licencing by the Game Council of New South Wales.

Following a report sharply criticizing the Game Council, the government dissolved it in mid-2013, suspended hunting on public lands, and reconsidered the plan to allow amateur hunters into national parks — thus breaking the earlier promise to the Shooters and Fishers Party.

Saturday, March 15, 2008

The Internet group Anonymous today held further protests critical of the Church of Scientology.

The global protests started in Australia where several hundred protesters gathered at different locations for peaceful protests.

In a global speech, the Internet protest movement said Scientology “betrayed the trust of its members, [had] taken their money, their rights, and at times their very lives.” The protesters welcomed the public interest their protests have led to, and claimed they witnessed “an unprecedented flood of Scientologists [joining] us across the world to testify about these abuses.” The group said it would continue with monthly actions.

In a press statement from its European headquarters, Scientology accused the anonymous protesters of “hate speech and hate crimes”, alleging that security measures were necessary because of death threats and bomb threats. This also makes the Church want to “identify members” of the group it brands as “cyber-terrorists”.

Wikinews had correspondents in a number of protest locations to report on the events.

Anonymous states that the next protest is scheduled to take place on April 18, which happens to be the birthday of Suri, the daughter of Tom and Katie Cruise.

Monday, June 23, 2008

2008 COMPUTEX Taipei, the largest trade fair since its inception in 1982, featured several seminars and forums, expansions on show spaces to TWTC Nangang, great transformations for theme pavilions, and WiMAX Taipei Expo, mainly promoted by Taipei Computer Association (TCA). Besides of ICT industry, “design” progressively became the critical factor for the future of the other industries. To promote innovative “Made In Taiwan” products, pavilions from “Best Choice of COMPUTEX”, “Taiwan Excellence Awards”, and newly-set “Design and Innovation (d & i) Award of COMPUTEX”, demonstrated the power of Taiwan’s designs in 2008 COMPUTEX Taipei.

Friday, March 3, 2006

Australian swimmer Ian Thorpe is reported to be feeling much better after suffering from chest pain for some time.

The Olympic gold medalist was due to swim in the 100m and 200m freestyle and in three relays at the Commonwealth Games, but due to his complaints his fitness has been in doubt. He has been unable to take the drugs needed to overcome his pain as they are banned from the Games.

Thorpe told the media Thursday “It’s actually the best I’ve felt in a while; the antibiotics are starting to work.”

Saturday, October 1, 2011

Last week, Nature Genetics carried twin studies into the genetics of bipolar disorder and schizophrenia. This special report examines the month’s research into the illnesses in detail, with Wikinews obtaining comment from experts based in Australia, the United States, and the United Kingdom ahead of the U.S. Mental Illness Awareness Week, which starts tomorrow.

Eleven genetic regions were identified; seven of these were for schizophrenia and five of those were hitherto undiscovered. The parallel studies, conducted separately, examined more than 50,000 people worldwide and identified two genetic loci associated with both diseases.

Little is known about the two illnesses, each of which affects around 1% of people and is treated with strong medication. Bipolar sufferers experience extremes of mood – depression and mania, hence the previous name “manic depression” for the illness. Schizophrenia is associated with hearing voices, chaotic thoughts, and paranoia. There is no known cure.

The latest research examined both the healthy and the afflicted, using computers to scan genomes. Inheritance was thought to be a factor from prior knowledge of the diseases as a familial trait, but the original desire had been to isolate a single faulty gene. Instead it has become apparent that the genetic factors are many; in the case of schizophrenia, at most around 30% of the genetic components are thought to have been identified.

The University of Chicago’s Pablo Gejman, a lead researcher on the schizophrenia study, explained to Wikinews in a telephone interview from Buenos Aires, Argentina that “One of the goals of genetic research is to find druggable targets” – to “find treatments at the root of the problem”.

Whilst noting that there is no guarantee the genetic code identified is druggable, Gejman named calcium-activated neurochemical channels in the brain as candidates for new drugs. The channels were linked to schizophrenia in the study.

Gejman explained that a genetic locus called mir137 “suggests an abnormality of gene regulation.” The diseases are so poorly understood that it is uncertain if they are in fact two components of a single spectrum, or even each comprised of multiple illnesses.

The new and “provocative data” gathered showed the significant loci identified were “not part of the pre-existent hypothesis.” Calling this “interesting”, Gejman added that the team found no evidence that dopamine receptors are involved; current drug treatments target dopamine receptors. The findings are “not related to anything we thought we knew [about schizophrenia],” he told our correspondent.

Quizzed about the possibility variations in the genetic factors involved in expressing the diseases explained the variation seen in symptoms, Gejman was uncertain. “We will have the answer, probably, only when we sequence the whole [human] genome.” He notes that the relationship between genotype and phenotype is unclear, and that “We know very little of the genetic architecture of schizophrenia and” other disorders.At the time the results were published, participating scientist Professor Rodney Scott from the University of Newcastle in Australia said “The strength of this research is in the numbers. The findings are robust and give us a lot of statistical power to identify the genetic determinants of schizophrenia.” Scott told Wikinews that “If any single centre tried to undertake such a study, it would require millions of pounds. Since it was a collection of data from across the world the costs were spread. In this era of financial difficulty it will become increasingly difficult to secure funding for this type of project even though the pay-offs will be significant.”

Gejman expressed similar sentiment. “The research budget is not growing, which makes [funding] difficult,” he said, though he felt the cost “is not prohibitive because of the benefits.” “I think that it was money well invested” and “very well spent for the future,” he said, adding that organisations in Europe and the US were aware of the importance of such research.

Gejman also agreed on reliability – the study is “Very reliable because of the sample size; that should provide robust results… [we] have worked with a much larger sample than before.” Scott told us it was “a highly reliable study” that has the potential to lead to new treatments “in the long run”.

Another point was the two genetic loci identified as common to both – how much support do they lend to the notion the diseases are linked? “Until more information is available it is really only suggestive,” says Scott. “Strong enough to say there may be potentially a common pathway that bifurcates to give rise to two diseases.”

“It is an excellent demonstration,” said Gejman “because you have the same chains that are common to both disorders, in fact not just the same chains but also the same alleles.” He stressed uncertainty in how strong the relationship was, however.

Scott said examining how the variation of genetic factors may translate into varied symptoms being expressed “certainly is a good target for future research”; “It is not known how many genetic factors contribute to either of these diseases but it is likely that not all are necessary to trigger disease.” “New questions will always arise from any major study,” he told our reporter. “Certainly, new questions about bipolar and schizophrenia are now able to be formulated on the basis of the results presented in the two reports.”

These weren’t the only studies to look at the two diseases together in September. The British Medical Journal carried research by a team from the University of Oxford and King’s College London that examined mortality rates in England for schizophrenia and bipolar sufferers. They found both groups continued to suffer higher mortality rates than the general population – whilst these included suicides, three quarters of deaths were down to ailments such a s heart conditions. General death rates dropped from 1999 to 2006, but sufferers below 65 saw their death rate remain stable – and the over-65 saw theirs increase.

“By 2006, the excess risk in these groups had risk to twice the rate of the general population, whereas prior to that it had only been 1.6 times the risk, so it increased by almost 40%,” said Dr Uy Hoang of Oxford. The study looked at every discharged inpatient with a diagnosis of either condition in England in the relevant time.

Hoang said at the time of the research’s release that doctors should devote attention to predicting and preventing physical illness associated with mental disorders. His study comes at a time when the UK has launched a “no health without mental health” strategy which does attempt to screen for physical illnesses coinciding with mental illnesses. The government aims to reduce the death rate of those with mental disorders.

Rodney Scott described this research result to Wikinews as “Possibly” connected to genetic association with other hereditary ailments, such as cardiovascular disease; he told us another possibility is that “The continued raised mortality rates may be associated with the diseases themselves.”

“We believe the NHS [National Health Service] and Department of Health need to do more to support research and service development for people with bipolar disorder,” Wikinews was told by Suzanne Hudson, Chief Executive of London-based British charity MDF The Bipolar Organisation. “The provision of specialist services for bipolar is very limited in the UK and the demand for our services is unprecedented.”

“A genetic test for bipolar would be a useful tool but the science and ethics are very complex,” Hudson told us, referring to the Nature Genetics genetic study. “Just because someone has ‘bipolar genes’ does not mean they might go on to develop it. Family studies of bipolar show that this is a likely outcome of genetics research in this area. Even if it were possible to accurately predict bipolar in this way, questions about how you treat that person are difficult. For example do you start medication that is not necessary at that point in time?”

“Current treatment is not satisfactory” because it does not always work and has “side effects,” Gejman told us. Robert Whitaker, a US medical journalist and book author, told an audience in New Zealand at the end of August that evidence suggests antidepressant drugs may make children and teenagers worse – “You see many become worse and end up with a more severe diagnosis, like bipolar illness,” and the suicide risk may increase.

Whitaker blames commercial interests. “The adult market appeared saturated, and so they began eying children and teenagers. Prior to this, few children and youth were seen as suffering from major depression, and so few were prescribed anti-depressants.”

One possible alternative, raised by a connection between depressive illness and inflammation, is aspirin and similar compounds. “The link between inflammation and mood disorders has been known for sometime and the use of aspirin and other drugs in depression is now becoming more common in the literature,” Hudson says. “Any new treatments for bipolar, which is a very complex and co-morbid illness, has to be a good thing.”

Professor Dr. Michael Berk, chairman of psychiatry at Australia’s Deakin University, recently gave a talk to just this effect. Speaking at this year’s Congress of the European College of Neuropsychopharmacology, held this past month, he also highlighted statins as a treatment. Recognising the link to physical ailments, he told an interviewer “The brain does not exist in isolation, and we need to understand that pathways similar to those that underpin risks for cardiovascular disorders, stroke, and osteoporosis might also underpin the risk for psychiatric disorders, and that other treatments might be helpful.”

Berk also touched upon speed of diagnosis and treatment; “Early interventions can potentially improve the outcome” of bipolar sufferers, he told his audience. MDF The Bipolar Organisation claim an average of ten years is possible before a person is diagnosed. “This clearly is an issue, if we believe that earlier diagnosis and treatment facilitate better outcomes,” Berk told Wikinews. Though he questions the effectiveness of currently-used drugs on advanced bipolar cases, he does not go so far as to say drugs are actively harmful. He told us “it appears that our best treatments work best earlier in the illness course; and that seems to apply to psychotherapy and pharmacotherapy.”

Berk has already performed research using statins which suggests they can form a treatment. He now seeks funding for research involving aspirin. On funding, he tells Wikinews “psychiatric disorders comprise between 16% and 22% of the burden of disability (depending on who measures it), attracts^[sic] just over 6% of the clinical budget at least in Australia and 3% of the research budget. Research as a discretionary spending item is at great risk.”

Berk’s research, in the past, has been funded by companies including GlaxoSmithKline. Hudson told Wikinews this did not concern her charity; in fact, they welcomed it. “We believe it is important pharmaceutical companies continue to invest in the development of new medications for bipolar. This is how it works in all other health specialities and mental health should be no different.”

“There is a need for greater education for mental health professionals and GPs [general practitioners] about bipolar [in the UK],” she told us. “As the national bipolar charity we receive many, many calls and requests from GPs and other health professionals for our leaflets and information sheets which is fantastic. We very much welcome opportunities to work together for the benefit of individuals affected by bipolar.”

Wikinews contacted the UK’s National Institute for Clinical Excellence (NICE) to discuss issues raised in this article, including future treatments, genetic screening, and mortality rates. NICE did not respond.

Might statins and/or aspirin improve treatment – might they be cheaper, perhaps, or safer? “This is an area of research promise,” says Berk, “however it is too early to make any clinical treatment claims; [all] we can say is that this needs to be studied in properly designed trials capable of giving a more definitive answer.” And what of possible explanations for the increased mortality rate observed in England? Should researchers look at whether bipolar influences more than just the brain, or if it is linked to other genetic conditions?

“For sure,” he told us. “There is new evidence that similar pathways contribute to the risk for both medical and psychiatric illness, both in terms of lifestyle factors, and biomarkers of risk.”

Thursday, September 13, 2007

Having worked as an aide, advisor, and Executive Assistant to municipal and provincial politicians, Sheila White is running for the Ontario New Democratic Party in the Ontario provincial election, in the Scarborough-Rouge River riding. Wikinews’ Nick Moreau interviewed her regarding her values, her experience, and her campaign.

Stay tuned for further interviews; every candidate from every party is eligible, and will be contacted. Expect interviews from Liberals, Progressive Conservatives, New Democratic Party members, Ontario Greens, as well as members from the Family Coalition, Freedom, Communist, Libertarian, and Confederation of Regions parties, as well as independents.